Curbstone Financial Management Decreased Cvs Health Corp. (Cvs) (CVS) Stake; 1 Analysts Covering Genesis Healthcare, Inc. (GEN)

CVS Health Corporation (NYSE:CVS) Logo

Curbstone Financial Management Corp decreased Cvs Health Corp. (Cvs) (CVS) stake by 67.39% reported in 2017Q4 SEC filing. Curbstone Financial Management Corp sold 14,980 shares as Cvs Health Corp. (Cvs) (CVS)’s stock declined 17.45%. The Curbstone Financial Management Corp holds 7,250 shares with $526,000 value, down from 22,230 last quarter. Cvs Health Corp. (Cvs) now has $63.17B valuation. The stock decreased 0.80% or $0.5 during the last trading session, reaching $62.21. About 8.10M shares traded. CVS Health Corporation (NYSE:CVS) has declined 22.81% since April 1, 2017 and is downtrending. It has underperformed by 34.36% the S&P500.

Among 6 analysts covering Genesis Healthcare (NYSE:GEN), 1 have Buy rating, 2 Sell and 3 Hold. Therefore 17% are positive. Genesis Healthcare had 17 analyst reports since August 10, 2015 according to SRatingsIntel. The stock of Genesis Healthcare, Inc. (NYSE:GEN) has “Hold” rating given on Monday, September 11 by RBC Capital Markets. The firm has “Outperform” rating given on Tuesday, January 26 by RBC Capital Markets. RBC Capital Markets maintained Genesis Healthcare, Inc. (NYSE:GEN) on Thursday, October 12 with “Hold” rating. The firm has “Hold” rating by RBC Capital Markets given on Monday, June 12. Cantor Fitzgerald maintained it with “Buy” rating and $700 target in Thursday, August 10 report. The company was maintained on Monday, November 9 by UBS. Bank of America downgraded the shares of GEN in report on Monday, May 16 to “Underperform” rating. RBC Capital Markets maintained it with “Hold” rating and $300 target in Monday, July 17 report. Stephens maintained it with “Hold” rating and $2.0 target in Monday, March 19 report. UBS downgraded the shares of GEN in report on Monday, February 8 to “Sell” rating. See Genesis Healthcare, Inc. (NYSE:GEN) latest ratings:

19/03/2018 Broker: Stephens Rating: Hold New Target: $2.0 Maintain
12/10/2017 Broker: RBC Capital Markets Rating: Hold New Target: $2.0 Maintain

The stock decreased 3.21% or $0.05 during the last trading session, reaching $1.51. About 663,013 shares traded. Genesis Healthcare, Inc. (NYSE:GEN) has declined 39.37% since April 1, 2017 and is downtrending. It has underperformed by 50.92% the S&P500.

Genesis HealthCare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company has market cap of $240.77 million. The firm operates through three divisions: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It currently has negative earnings. It also provides a range of rehabilitation therapy services, including speech pathology, physical therapy, occupational therapy, and respiratory therapy.

Since October 2, 2017, it had 0 buys, and 1 sale for $1.42 million activity. Another trade for 19,965 shares valued at $1.42 million was sold by Foulkes Helena. $1.67 million worth of stock was sold by Moriarty Thomas M on Monday, October 2.

Investors sentiment decreased to 0.72 in 2017 Q4. Its down 0.16, from 0.88 in 2017Q3. It dived, as 115 investors sold CVS shares while 600 reduced holdings. 134 funds opened positions while 380 raised stakes. 815.59 million shares or 1.76% more from 801.45 million shares in 2017Q3 were reported. Acadian Asset Mgmt Ltd Liability Company stated it has 9,779 shares or 0% of all its holdings. The Missouri-based Bush Odonnell Investment Advisors has invested 2.76% in CVS Health Corporation (NYSE:CVS). Korea Invest reported 0.29% of its portfolio in CVS Health Corporation (NYSE:CVS). Mastrapasqua Asset Inc reported 0.06% of its portfolio in CVS Health Corporation (NYSE:CVS). Fjarde Ap, a Alabama-based fund reported 284,231 shares. Westwood Mgmt Il has 4,100 shares. Perigon Wealth Mgmt Limited Liability Co has invested 0.81% in CVS Health Corporation (NYSE:CVS). King Luther Cap holds 140,979 shares. Summit Asset Management reported 0.18% in CVS Health Corporation (NYSE:CVS). Pensionfund Dsm Netherlands has invested 0.63% of its portfolio in CVS Health Corporation (NYSE:CVS). New York State Teachers Retirement System invested 0.31% of its portfolio in CVS Health Corporation (NYSE:CVS). 250,597 are owned by Lpl Fincl Llc. 31 were accumulated by Alphamark Advsr Limited Liability Corporation. Toronto Dominion Savings Bank holds 0.1% or 477,273 shares in its portfolio. Whittier Tru Of Nevada reported 53,549 shares.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on May, 1. They expect $1.40 EPS, up 19.66% or $0.23 from last year’s $1.17 per share. CVS’s profit will be $1.42 billion for 11.11 P/E if the $1.40 EPS becomes a reality. After $1.92 actual EPS reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts -27.08% negative EPS growth.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart